{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:58:43Z","timestamp":1787752723831,"version":"build-2784847793"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":120,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ymthe.2024.10.031","type":"journal-article","created":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T10:33:04Z","timestamp":1733653984000},"page":"2851-2871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Flavopiridol restores granulopoiesis in experimental models of severe congenital neutropenia"],"prefix":"10.1016","volume":"33","author":[{"given":"Masoud","family":"Nasri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Dannenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Doll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bet\u00fcl","family":"Findik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franka","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Kandabarau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksim","family":"Klimiankou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meinrad","family":"Gawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lengerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Zeidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Welte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4399-2324","authenticated-orcid":false,"given":"Julia","family":"Skokowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2024.10.031_bib1","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1182\/blood.V88.6.1907.bloodjournal8861907","article-title":"Filgrastim (r-metHuG-CSF): the first 10 years","volume":"88","author":"Welte","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.031_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.seminhematol.2006.04.004","article-title":"Severe congenital neutropenia","volume":"43","author":"Welte","year":"2006","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00062752-200701000-00006","article-title":"Severe congenital neutropenia: inheritance and pathophysiology","volume":"14","author":"Skokowa","year":"2007","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib4","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood.V81.10.2496.2496","article-title":"A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia","volume":"81","author":"Dale","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.031_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/70544","article-title":"Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis","volume":"23","author":"Horwitz","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.10.031_bib6","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1182\/blood.V96.7.2317","article-title":"Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia","volume":"96","author":"Dale","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.031_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ng1940","article-title":"HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)","volume":"39","author":"Klein","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.10.031_bib8","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1182\/blood-2017-12-820308","article-title":"Mutations in the SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome","volume":"132","author":"Bellann\u00e9-Chantelot","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.031_bib9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/ng.3069","article-title":"JAGN1 deficiency causes aberrant myeloid cell homeostasis and congenital neutropenia","volume":"46","author":"Boztug","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.10.031_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MOH.0000000000000105","article-title":"The diversity of mutations and clinical outcomes for ELANE-associated neutropenia","volume":"22","author":"Makaryan","year":"2015","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib11","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nm1474","article-title":"LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia","volume":"12","author":"Skokowa","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.10.031_bib12","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/nm.2958","article-title":"Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF\u2013triggered granulopoiesis","volume":"18","author":"Skokowa","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.10.031_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nm.1913","article-title":"NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD+-sirtuin-1-dependent pathway","volume":"15","author":"Skokowa","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2024.10.031_bib14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/bjh.17313","article-title":"Nicotinamide (vitamin B3) treatment improves response to G-CSF in severe congenital neutropenia patients","volume":"192","author":"Deordieva","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41434-020-0127-y","article-title":"Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells","volume":"27","author":"Hoffmann","year":"2020","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2024.10.031_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature06604","article-title":"Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons","volume":"452","author":"Chao","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2024.10.031_bib17","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1182\/blood-2010-10-311704","article-title":"Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane","volume":"117","author":"Nanua","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.031_bib18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.stem.2020.12.015","article-title":"Dissecting ELANE neutropenia pathogenicity by human HSC gene editing","volume":"28","author":"Rao","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2024.10.031_bib19","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ymthe.2024.03.037","article-title":"CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia","volume":"32","author":"Nasri","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2024.10.031_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.stem.2013.09.002","article-title":"Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors","volume":"13","author":"Doulatov","year":"2013","journal-title":"Cell stem cell"},{"key":"10.1016\/j.ymthe.2024.10.031_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.exphem.2018.12.006","article-title":"Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation","volume":"71","author":"Dannenmann","year":"2019","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.stem.2021.03.023","article-title":"iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia","volume":"28","author":"Dannenmann","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2024.10.031_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125157","article-title":"Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells","volume":"4","author":"Ruiz-Gutierrez","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2024.10.031_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5645","article-title":"Drug discovery for Diamond-Blackfan anemia using reprogrammed hematopoietic progenitors","volume":"9","author":"Doulatov","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2024.10.031_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-1-0716-0290-4_27","article-title":"CRISPR\/Cas9 genome editing of human-induced pluripotent stem cells followed by granulocytic differentiation","volume":"2115","author":"Dannenmann","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib26","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1101\/gr.175141.114","article-title":"DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly","volume":"24","author":"Scheinin","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2024.10.031_bib27","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3324\/haematol.2019.221804","article-title":"CRISPR\/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients","volume":"105","author":"Nasri","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.ymthe.2024.10.031_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/bjh.13823","article-title":"ELANE mutant\u2013specific activation of different UPR pathways in congenital neutropenia","volume":"172","author":"Nustede","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib30","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"g: Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.10.031_bib31","doi-asserted-by":"crossref","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","article-title":"The reactome pathway knowledgebase","volume":"46","author":"Fabregat","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.10.031_bib32","doi-asserted-by":"crossref","first-page":"W171","DOI":"10.1093\/nar\/gky458","article-title":"eXpression2Kinases (X2K) Web: linking expression signatures to upstream cell signaling networks","volume":"46","author":"Clarke","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymthe.2024.10.031_bib33","doi-asserted-by":"crossref","first-page":"16015","DOI":"10.1038\/npjsba.2016.15","article-title":"L1000CDS2: LINCS L1000 characteristic direction signatures search engine","volume":"2","author":"Duan","year":"2016","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.ymthe.2024.10.031_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrc2044","article-title":"The Connectivity Map: a new tool for biomedical research","volume":"7","author":"Lamb","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymthe.2024.10.031_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2024.10.031_bib36","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2024.10.031_bib37","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1128\/MCB.18.7.4301","article-title":"CCAAT\/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors","volume":"18","author":"Radomska","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib38","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1182\/blood.V99.12.4406","article-title":"Induction of granulocytic differentiation by 2 pathways","volume":"99","author":"Zhang","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.031_bib39","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/blood-2002-05-1546","article-title":"Induction of C\/EBPalpha activity alters gene expression and differentiation of human CD34+ cells","volume":"101","author":"Cammenga","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.031_bib40","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/MCB.24.2.675-686.2004","article-title":"Phosphorylation of C\/EBPalpha inhibits granulopoiesis","volume":"24","author":"Ross","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib41","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1182\/blood-2005-06-2216","article-title":"C\/EBPalpha determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation","volume":"107","author":"Suh","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.031_bib42","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1097-2765(01)00366-5","article-title":"C\/EBP\u03b1 arrests cell proliferation through direct inhibition of Cdk2 and Cdk4","volume":"8","author":"Wang","year":"2001","journal-title":"Mol. Cel"},{"key":"10.1016\/j.ymthe.2024.10.031_bib43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1040-8428(00)00124-4","article-title":"Mechanisms of action of flavopiridol","volume":"38","author":"Sedlacek","year":"2001","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib44","series-title":"Transcriptional regulation of granulopoiesis. Release#V85","author":"May","year":"2023"},{"key":"10.1016\/j.ymthe.2024.10.031_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1089\/crispr.2020.0022","article-title":"Deconvolution of complex DNA repair (DECODR): establishing a novel deconvolution algorithm for comprehensive analysis of CRISPR-edited sanger sequencing data","volume":"4","author":"Bloh","year":"2021","journal-title":"CRISPR J."},{"key":"10.1016\/j.ymthe.2024.10.031_bib46","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10616-014-9796-y","article-title":"Characteristics of hematopoietic stem cells of umbilical cord blood","volume":"67","author":"Hordyjewska","year":"2015","journal-title":"Cytotechnology"},{"key":"10.1016\/j.ymthe.2024.10.031_bib47","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3324\/haematol.2019.240200","article-title":"A zebrafish model for HAX1-associated congenital neutropenia","volume":"106","author":"Doll","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.ymthe.2024.10.031_bib48","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1182\/bloodadvances.2023011656","article-title":"A JAGN1-associated severe congenital neutropenia zebrafish model revealed an altered G-CSFR signaling and UPR activation","volume":"8","author":"Doll","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymthe.2024.10.031_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1196\/annals.1392.012","article-title":"LEF-1 is a decisive transcription factor in neutrophil granulopoiesis","volume":"1106","author":"Skokowa","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ymthe.2024.10.031_bib50","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1182\/blood-2012-09-456889","article-title":"Bortezomib inhibits STAT5-dependent degradation of LEF-1, inducing granulocytic differentiation in congenital neutropenia CD34(+) cells","volume":"123","author":"Gupta","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.031_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.32","article-title":"Severe congenital neutropenias","volume":"3","author":"Skokowa","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2024.10.031_bib52","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1182\/blood-2002-05-1372","article-title":"Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis","volume":"100","author":"Grenda","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.031_bib53","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.leukres.2015.10.010","article-title":"Clinical activity of alvocidib (flavopiridol) in acute myeloid leukemia","volume":"39","author":"Zeidner","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ymthe.2024.10.031_bib54","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1200\/JCO.1998.16.9.2986","article-title":"Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms","volume":"16","author":"Senderowicz","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib55","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1517\/13543784.2016.1169273","article-title":"Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia","volume":"25","author":"Wiernik","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ymthe.2024.10.031_bib56","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1158\/1078-0432.CCR-16-2629","article-title":"Exposure-Response Analysis of Alvocidib (Flavopiridol) Treatment by Bolus or Hybrid Administration in Newly Diagnosed or Relapsed\/Refractory Acute Leukemia Patients","volume":"23","author":"LaCerte","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2024.10.031_bib57","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1200\/JCO.2002.01.043","article-title":"Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms","volume":"20","author":"Tan","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib58","doi-asserted-by":"crossref","first-page":"28345","DOI":"10.1074\/jbc.C000446200","article-title":"Flavopiridol inhibits P-TEFb and blocks HIV-1 replication","volume":"275","author":"Chao","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2024.10.031_bib59","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/ATVBAHA.110.213934","article-title":"Flavopiridol protects against inflammation by attenuating leukocyte-endothelial interaction via inhibition of cyclin-dependent kinase 9","volume":"31","author":"Schmerwitz","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib60","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nchembio.90","article-title":"A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity","volume":"4","author":"Montagnoli","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib61","first-page":"1393","article-title":"Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring ELANE mutations","volume":"109","author":"Zeidler","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.ymthe.2024.10.031_bib62","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1080\/15384101.2016.1231283","article-title":"Effects of cyclin dependent kinase 9 inhibition on zebrafish larvae","volume":"15","author":"Matrone","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ymthe.2024.10.031_bib63","article-title":"Genetic and pharmacological inhibition of CDK9 drives neutrophil apoptosis to resolve inflammation in zebrafish in vivo","volume":"5","author":"Hoodless","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2024.10.031_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011308","article-title":"Myeloid Targeted Human MLL-ENL and MLL-AF9 Induces cdk9 and bcl2 Expression in Zebrafish Embryos","volume":"20","author":"Belt","year":"2024","journal-title":"Plos Genet."},{"key":"10.1016\/j.ymthe.2024.10.031_bib65","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2021.03.042","article-title":"Development and characterization of a novel flavopiridol formulation for treatment of acute myeloid leukemia","volume":"333","author":"Chen","year":"2021","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2024.10.031_bib66","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1158\/1538-7445.AM2017-5133","article-title":"TP-1287, an oral prodrug of the cyclin-dependent kinase-9 inhibitor alvocidib","volume":"77","author":"Kim","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2024.10.031_bib67","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.biomaterials.2013.11.024","article-title":"Promoter and lineage independent anti-silencing activity of the A2 ubiquitous chromatin opening element for optimized human pluripotent stem cell-based gene therapy","volume":"35","author":"Ackermann","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ymthe.2024.10.031_bib68","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2024.10.031_bib69","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","article-title":"iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data","volume":"19","author":"Ge","year":"2018","journal-title":"BMC bioinformatics"},{"key":"10.1016\/j.ymthe.2024.10.031_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.107","article-title":"Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp","volume":"2","author":"Chen","year":"2023","journal-title":"Imeta"},{"key":"10.1016\/j.ymthe.2024.10.031_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"Gigascience"},{"key":"10.1016\/j.ymthe.2024.10.031_bib72","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00793-18","article-title":"Zebrafish Granulocyte Colony-Stimulating Factor Receptor Maintains Neutrophil Number and Function throughout the Life Span","volume":"87","author":"Basheer","year":"2019","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2024.10.031_bib73","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1182\/blood-2005-01-0179","article-title":"Analysis of thrombocyte development in CD41-GFP transgenic zebrafish","volume":"106","author":"Lin","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2024.10.031_bib74","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.mod.2004.03.031","article-title":"Large-scale expression screening by automated whole-mount in situ hybridization","volume":"121","author":"Quiring","year":"2004","journal-title":"Mech. Dev."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624007275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001624007275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T21:13:23Z","timestamp":1759612403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001624007275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1525001624007275"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.031","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flavopiridol restores granulopoiesis in experimental models of severe congenital neutropenia","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}